Reducing Tuberculosis Incidence by Tuberculin Skin Testing, Preventive Treatment, and Antiretroviral Therapy in an Area of Low Tuberculosis Transmission
Author(s) -
Luigia Elzi,
Matthias Schlegel,
Rainer Weber,
Bernard Hirschel,
Matthias Cavassini,
Patrick Schmid,
Enos Bernasconi,
Martin Rickenbach,
Hansjakob Furrer
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/510080
Subject(s) - medicine , tuberculosis , tuberculin , incidence (geometry) , epidemiology , hazard ratio , transmission (telecommunications) , confidence interval , history of tuberculosis , cohort , cohort study , pediatrics , pathology , electrical engineering , optics , engineering , physics
Tuberculin skin testing (TST) and preventive treatment of tuberculosis (TB) are recommended for all persons with human immunodeficiency virus (HIV) infection. We aimed to assess the effect of TST and preventive treatment of TB on the incidence of TB in the era of combination antiretroviral therapy in an area with low rates of TB transmission.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom